The influence of BESTFertil towards male reproductive function in idiopathic fertility

Abstract

The study objective is to evaluate the influence of complex BESTFertil on the fertility in men with idiopathic pathospermia.Materials and methods. Ninety males (from 25 to 45years old) took part in the open prospective controlled study: 60 males with idiopathic fertility were given BESTFertil (2 caps “Morning” and 2 caps “Evening” per day for the period of 3 month). Other 30 males belong to controls. The efficacy of therapeutics was evaluated according to spermatogram analysis (volume of ejaculate, sperm concentration, percentage of progressive-motile sperm (grade A + B), and percentage of degenerated forms).Results. After 3 month of treatment the ejaculate volume increased to 1,7 time, and exceeded controls up. The sperm concentration increased to 33 % (before treatment) and exceeded controls to 39 %. The percentage of progressive-motile sperm (grade A + B) was 6 times more as it was before treatment, and 89,8 % as compare to the controls. The percentage of degenerated forms of spermatozoids decreased to 32,3 % (before treatment) and was 2,9 % less then in the control group.Conclusions. Administration of BESTFertil in treatment plan of male idiopathic fertility may consider to be a promising type of therapy, which increased the records of spermatogram and promotes conception among the married couples.

Keywords

• male idiopathic fertility
• spermatogram
• antioxidants
• pharmaceutical product bestfertil